| Banno B, Ickenstein LM, Chiu GN, et al. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. [JOURNAL ARTICLE] J Pharm Sci 2009 Nov 9. Abstract | Full Citation | | Obata Y, Tajima S, Takeoka S Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. [JOURNAL ARTICLE] J Control Release 2009 Oct 24. Abstract | Full Citation | Find Related Articles | | Buhl T, Bertsch HP, Kaune KM, et al. Low-Dose Gemcitabine Efficacious in Three Patients With Tumor-Stage Mycosis Fungoides. [JOURNAL ARTICLE] Clin Lymphoma Myeloma 2009 Oct 1; 9(5):E21-E24. Abstract | Full Citation | | Livi L, Meattini I, Cardillo Cde L, et al. Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: a retrospective analysis. [Journal Article] Tumori 2009 Jul-Aug; 95(4):422-6. Abstract | Full Citation | | Volpe DA, Shaw AB, Chen XH, et al. Effect of altered temperature storage on the in vitro cellular uptake of liposome drug products. [JOURNAL ARTICLE] J Liposome Res 2009 Oct 22. Abstract | Full Citation | | Dai W, Yang T, Wang X, et al. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells. [JOURNAL ARTICLE] J Drug Target 2009 Oct 13. Abstract | Full Citation | | Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. [JOURNAL ARTICLE] J Control Release 2009 Oct 8. Abstract | Full Citation | | Rusetskaya NV, Lukyanova NY, Chekhun VF Molecular profile and cell cycle in mcf-7 and mcf‑7/dox cells exposed to conventional and liposomal forms of doxorubicin. [JOURNAL ARTICLE] Exp Oncol 2009 Sep; 31(3):FirstPage-LastPage. Abstract | Full Citation | | Gabizon A, Tzemach D, Gorin J, et al. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. [JOURNAL ARTICLE] Cancer Chemother Pharmacol 2009 Sep 25. Abstract | Full Citation | Find Related Articles | | Buda G, Orciuolo E, Galimberti S, et al. Bortezomib and Liposomal Doxorubicin Are Highly Effective in Obtaining the Best Possible Response before Autologous Transplant for Multiple Myeloma. [JOURNAL ARTICLE] Acta Haematol 2009 Aug 29; 122(1):39-41. Full Citation |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|